This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
This article breaks down the components that feed a Total Return Index, including price changes, dividends, and corporate actions, and explains how they combine to show true performance.
28,383 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Nebius has sprinted ahead in 2026, climbing 170% as AI infrastructure accelerates. This article breaks down the drive...
Tech founder moves set a high bar for OpenAI's IPO. This article breaks down the reality behind altman called openai ...
Nvidia's surge in AI chips is reshaping markets, and some analysts frame it as a $200 billion warning for rivals like...
A wave of withdrawals from Bitcoin ETFs has traders wondering if the dip is a trap or a buying opportunity. This guid...
Steak ’n Shake reports a 16% July lift in U.S. same-store sales and attributes it to Bitcoin adoption, but the absenc...
NVIDIA’s new alliance with Meta Platforms tightens the AI infrastructure backbone, pushing AMD to the back foot as in...
When a CFO discloses a sizable stake sale during a volatile period, investors scramble for context. This article brea...
Nvidia stands at a crossroads as it prepares to report Feb earnings. This article unpacks why the result could redefi...
A Wall Street analyst has highlighted Alphabet's growing AI capabilities, suggesting a shift in the AI compute landsc...
Markets are chasing a quiet AI hardware rotation. The hidden trade already just rallied 31% in a month, led by memory...
Healthcare costs loom large for retirees and investors alike. This article argues that one AI-driven healthcare leade...